Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sutcliffe

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
JAMA|October 26, 1979
Cytotoxic chemotherapy and gonadal function in patients with Hodgkin's disease. Facts and thoughtsS B Sutcliffe
Cancer|April 28, 2011
A review of Canadian health care and cancer care systemsSimon B Sutcliffe
Current Oncology (Toronto, Ont.)|September 5, 2008
Integrating science and human values for cancer patient careS B Sutcliffe
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1985
Treatment of neoplastic disease during pregnancy: maternal and fetal effectsS B Sutcliffe
Healthcare Management Forum|December 22, 2017
Planning for cancer control programs: Leadership considerationsJohn French, Simon B Sutcliffe
Leukemia & Lymphoma|March 1, 1995
Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphomaG Dranitsaris, S B Sutcliffe
Current Problems in Diagnostic Radiology|June 26, 2013
Controversies in breast MRIJoseph B Sutcliffe, Pamela M Otto
Clinical and Experimental Immunology|November 1, 1982
In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of responseA A Gottlieb, S B Sutcliffe
Blood|October 1, 1981
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's diseaseR M Chapman, S B Sutcliffe
The International Journal on Drug Policy|June 19, 2021
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harmsRob Ralphs, Paul Gray, Oliver B Sutcliffe
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
JAMA|October 26, 1979
Cytotoxic chemotherapy and gonadal function in patients with Hodgkin's disease. Facts and thoughtsS B Sutcliffe
Cancer|April 28, 2011
A review of Canadian health care and cancer care systemsSimon B Sutcliffe
Current Oncology (Toronto, Ont.)|September 5, 2008
Integrating science and human values for cancer patient careS B Sutcliffe
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1985
Treatment of neoplastic disease during pregnancy: maternal and fetal effectsS B Sutcliffe
Healthcare Management Forum|December 22, 2017
Planning for cancer control programs: Leadership considerationsJohn French, Simon B Sutcliffe
Leukemia & Lymphoma|March 1, 1995
Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphomaG Dranitsaris, S B Sutcliffe
Current Problems in Diagnostic Radiology|June 26, 2013
Controversies in breast MRIJoseph B Sutcliffe, Pamela M Otto
Clinical and Experimental Immunology|November 1, 1982
In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of responseA A Gottlieb, S B Sutcliffe
Blood|October 1, 1981
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's diseaseR M Chapman, S B Sutcliffe
The International Journal on Drug Policy|June 19, 2021
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harmsRob Ralphs, Paul Gray, Oliver B Sutcliffe
Pageof 14